Description
Utilize our Serum Amyloid A (SAA) / ADAMTS13 2-Plex Panel for a focused assessment of acute phase inflammatory detection, chronic inflammatory diseases.
Serum amyloid A (SAA) is a crucial biomarker present in serum and plasma that spikes during acute inflammatory responses. It regulates immune cells and maintains a balance between pro-inflammatory and anti-inflammatory factors, making it a reliable indicator for autoimmune and rheumatic diseases, including rheumatoid arthritis, familial Mediterranean fever, sarcoidosis, and vasculitis.
ADAMTS13 is vital for clot resolution, cleaving von Willebrand factor (VWF) to prevent excessive platelet recruitment. While essential in thrombotic thrombocytopenic purpura (TTP) and von Willebrand disease (VWD), it may also play a role in other vascular inflammation disorders.
Reduced ADAMTS13 levels have been noted in long COVID patients, indicating hemostatic dysregulation, while SAA is associated with hyperinflammation in COVID-19.
A number of biomarkers detected in this panel are specifically associated with coagulation, which make serum an unacceptable sample type for this assay. The Serum Amyloid A (SAA) / ADAMTS13 2-Plex Panel is recommended for plasma only, EDTA preferred, and CSF (SAA only) samples.
Our certification as a High Complexity International Laboratory by the Centers for Medicare & Medicaid Services (CMS) (CLIA# 99D2283230) underscores our commitment to rigorous standards.
Key Features:
- Focused Biomarker Coverage: Provides a focused analysis of two key biomarkers, ensuring a thorough diagnostic approach.
- CLIA Certified for Clinical Use: As a CLIA certified laboratory, we provide a panel that meets the highest standards of accuracy and reliability for clinical diagnostics.
- Versatility: Use this panel to investigate acute phase inflammatory detection, chronic inflammatory diseases.
- Sample flexibility: Are available for PLASMA-EDTA and CSF (SAA only) samples.
- Affordable Assay Services: We offer some of the most affordable assay services available, making advanced diagnostics accessible for clinical applications.
Discover the power of precision with our Serum Amyloid A (SAA) / ADAMTS13 2-Plex Panel, expertly designed for the Luminex® 200™ platform. This cutting-edge technology enables the simultaneous detection of multiple biomarkers from a minimal single sample, delivering comprehensive insights with unmatched efficiency.
Swift and Reliable Turnaround Time
Trust us for a swift and reliable experience. We pride ourselves on a rapid turnaround time, with results typically delivered within 5 business days of receiving your specimen and payment. With our commitment to precision and efficiency, you can count on us to provide the insights you need, promptly and accurately.
Certified Excellence in Diagnostic Testing
Eve Technologies is certified by the Centers for Medicare & Medicaid Services (CMS) as a High Complexity International Laboratory under the Clinical Laboratory Improvement Amendments (CLIA), specializing in Diagnostic Immunology with a subspecialty in General Immunology (CLIA# 99D2283230). Additionally, we hold a clinical and public health laboratory license with the California Department of Public Health (COS-90013367). Our certification underscores our commitment to rigorous standards.
Clinicians: Please check with your State Agency to determine if additional licensure or registration requirements may apply.
Regulated tests: Ensuring Quality and Accuracy
The LDT (Lab Developed Test) designation highlights that our tests are regulated by the Centers for Medicare & Medicaid Services (CMS) under CLIA, ensuring they meet stringent quality and accuracy standards. Unlike commercially distributed tests, which undergo FDA approval, our LDTs are developed and validated within our laboratory to provide specialized and reliable diagnostic insights tailored to your needs. This distinction underscores our commitment to maintaining the highest standards in testing and personalized care.
! The interpretation of these test results should be correlated with clinical findings and other diagnostic tests. Biomarker levels can vary due to many biological, physiological, and diurnal factors; their clinical significance must be assessed by a qualified healthcare professional. This information is not intended to be used as the sole basis for diagnosis or treatment decisions. ​